PLEASANTON, Calif., Jan. 03, 2017 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that it has completed the acquisition of GN Otometrics from GN Store Nord A/S (GN.CO) that was announced on September 26, 2016. Based in Taastrup, Denmark, Otometrics provides hearing screening, hearing diagnostic and balance care tools and software to hospitals and professional worldwide.
About Otometrics
Otometrics is a leader in the hearing and balance assessment market. Otometrics provides computer-based audiological, otoneurologic and vestibular instrumentation and sound rooms to hearing and balance care professionals worldwide. Otometrics has a complete product and brand portfolio known for its sophisticated design technology in the hearing and balance assessment markets. Global brands include Aurical®, ICS® and Madsen®.
Additional information about GN Otometrics can be found at www.otometrics.com.
About Natus Medical Incorporated
Natus is a leading provider of healthcare products and services used in the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders.
Additional information about Natus Medical can be found at www.natus.com.
COMPANY CONTACT: Natus Medical Incorporated Jonathan A. Kennedy Executive Vice President Finance and Chief Financial Officer (925) 223-6700 [email protected]


EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 



